Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS USA

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 46
  • 0 comments

FDA approve DULOXETINE HYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 43
  • 0 comments

FDA approve CABAZITAXEL

Comment Full text

MLV

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 45
  • 0 comments

FDA approve CARVEDILOL

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 11, 2024, 08:41 UTC
  • 42
  • 0 comments

FDA approve PROPRANOLOL HYDROCHLORIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Oct. 11, 2024, 04:30 UTC
  • 48
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

EPIC PHARMA

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 45
  • 0 comments

FDA approve SULINDAC

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 44
  • 0 comments

FDA approve DIMETHYL FUMARATE

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 50
  • 0 comments

FDA approve PACLITAXEL

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 46
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 10, 2024, 08:41 UTC
  • 41
  • 0 comments

FDA approve LAMOTRIGINE

Comment Full text
  • Previous
  • 335
  • 336
  • 337
  • 338
  • 339
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137453)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin